fb-pixel Skip to main content
Health and biotech

Latest stories

More biotech and health care stories

Somerville-based Bluebird Bio expects delay on FDA sickle cell drug application

The company nearly ran out of cash in 2022 as a series of safety scares related to lovo-cel delayed its efforts to seek regulatory approval for the drug by more than a year.

Nantucket, Middlesex top list of healthiest counties in Massachusetts, new survey shows

How long you live depends on where you live, according to the new report.


Union votes ‘no confidence’ in Women & Infants Hospital management

SEIU District 1199 members cite an ongoing labor shortage, and allege a “historic number” of unresolved grievances and arbitrations, and an “ongoing lack of clear and respectful” communication.

Jury awards $20 million to man who lost a leg after hospital missed blood clot

The patient twice went to Lowell General complaining of pain, but his blood clot was misdiagnosed as sciatica.

‘I have to take my time.’ Growing old in Boston without much money is an everyday stress test.

Cracked sidewalks, patchy transit, the lurking possibility of violence. For older Bostonians of limited means, much of life is a struggle to get around, find connections, and make ends meet.

Biogen’s ALS drug gets partial backing from FDA panel

If approved, the medication, tofersen, would be the first drug targeting a specific genetic cause of the incurable paralysis disease to get the regulatory green light.

At Senate hearing, Bernie Sanders grills Moderna CEO for quadrupling COVID vaccine price

Moderna has previously said it will make its COVID shots freely available to anyone without insurance, but senators were skeptical about how that would work.

State officials issue guidance to Mass. pharmacies: stock abortion pills

Officials said Mass. pharmacies must stock all reproductive health medications including mifepristone, a drug that can safely end a pregnancy in its early stages.